HeartSciences Inc Warrant
HSCSW
3 hedge funds and large institutions have $43K invested in HeartSciences Inc Warrant in 2025 Q2 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
86% more capital invested
Capital invested by funds: $23.1K → $43K (+$19.8K)
0% more funds holding
Funds holding: 3 → 3 (0)
20.61% less ownership
Funds ownership: 51.04% → 30.43% (-21%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$611 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$94 |
| 2 |
CS
Clear Street
New York
|
-$22 |
HSCSW Hedge Fund Activity: Q2 2025 in Review
3 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in HeartSciences Inc Warrant (HSCSW) for Q2 2025, worth a combined $43K — up 86% from $23.1K a quarter earlier.
Fund positioning in HSCSW was balanced in Q2 2025: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $611. The largest seller was Citadel Advisors, cutting an estimated $94.
- 3 institutional investors held HeartSciences Inc Warrant (HSCSW) as of Q2 2025, unchanged from Q1 2025.
- Funds reported $43K of HeartSciences Inc Warrant stock for Q2 2025, up 86% quarter-over-quarter.
- 0 funds opened new HeartSciences Inc Warrant positions in Q2 2025 and 0 closed out.
- The largest HeartSciences Inc Warrant buyer in Q2 2025 was Susquehanna International Group, an estimated $611 added.
- The largest HeartSciences Inc Warrant seller in Q2 2025 was Citadel Advisors, an estimated $94 sold.
Based on aggregated 13F filings for Q2 2025.